JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halim, A.-B.
Right arrow Articles by Kotb, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halim, A.-B.
Right arrow Articles by Kotb, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 42, 29720-29725, October 15, 1999


Expression and Functional Interaction of the Catalytic and Regulatory Subunits of Human Methionine Adenosyltransferase in Mammalian Cells*

Abdel-Baset HalimDagger §, Leighton LeGrosDagger §, Arthur Geller, and Malak KotbDagger §parallel **

From the Departments of Dagger  Surgery, parallel  Microbiology and Immunology, and  Biochemistry, University of Tennessee, Memphis, Tennessee 38104 and the § Veterans Affairs Medical Center, Memphis, Tennessee 38104

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Methionine adenosyltransferase (MAT) catalyzes the synthesis of S-adenosylmethionine (AdoMet). The mammalian MAT II isozyme consists of catalytic alpha 2 and regulatory beta  subunits. The aim of this study was to investigate the interaction and kinetic behavior of the human MAT II subunit proteins in mammalian cells. COS-1 cells were transiently transfected with pTargeT vector harboring full-length cDNA that encodes for the MAT II alpha 2 or beta  subunits. Expression of the His-tagged recombinant alpha 2 (ralpha 2) subunit in COS-1 cells markedly increased MAT II activity and resulted in a shift in the Km for L-methionine (L-Met) from 15 µM (endogenous MAT II) to 75 µM (ralpha 2), and with the apparent existence of two kinetic forms of MAT in the transfected COS-1 cell extracts. By contrast, expression of the recombinant beta  (rbeta ) subunit had no effect on the Km for L-Met of the endogenous MAT II, while it did cause an increase in both the Vmax and the specific activity of endogenous MAT. Co-expression of both ralpha 2 and rbeta subunits resulted in a significant increase of MAT specific activity with the appearance of a single kinetic form of MAT (Km = 20 µM). The recombinant MAT II alpha 2 and rbeta subunit associated spontaneously either in cell-free system or in COS-1 cells co-expressing both subunits. Analysis of nickel-agarose-purified His-tagged ralpha 2 subunit from COS-1 cell extracts showed that the beta  subunit co-purified with the alpha 2 subunit. Furthermore, the alpha 2 and beta  subunits co-migrated in native polyacrylamide gels. Together, the data provide evidence for alpha 2 and beta  MAT subunit association. In addition, the beta  subunit regulated MAT II activity by reducing its Km for L-Met and by rendering the enzyme more susceptible to feedback inhibition by AdoMet. We believe that the previously described differential expression of MAT II beta  subunit may be an important mechanism by which MAT activity can be modulated to provide different levels of AdoMet that may be required at different stages of cell growth and differentiation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Methionine adenosyltransferase (MAT)1 (ATP:L-methionine S-adenosyltransferase) (EC 2.5.1.6) catalyzes the biosynthesis of S-adenosylmethionine (AdoMet) from L-methionine (L-Met) and ATP (1). AdoMet is the major methyl donor in transmethylation reactions, including the methylation of DNA, RNA, proteins, and other small molecules. Further, AdoMet is the propylamine donor in the biosynthesis of polyamines (2-5), and it participates as a co-factor in key metabolic pathways (6-8). Inasmuch as AdoMet plays a pivotal role in metabolism, it is not surprising that most species studied to date have more than one MAT isozyme (3).

Mammalian MAT exists in multiple forms that differ in their physical and kinetic properties among distinct species and even among different tissues of the same species. In mammals there are three forms, designated MAT I, II, and III, that differ in their tissue distribution and kinetic properties (7, 9-11). MAT I and III are referred to as the hepatic forms because their expression is confined to the liver. By contrast, MAT II is found in all mammalian tissues that have been examined to date, including erythrocytes, lymphocytes, brain, kidney, testis, and liver (10, 12-18). MAT I is a tetramer and MAT III is a dimer of an identical catalytic subunit, alpha 1, encoded by the MATIA gene (7, 19-22). On the other hand MAT II from leukemic T cells or from activated human lymphocytes is a hetero-oligomer that consists of alpha 2 (53 kDa), alpha '2 (51 kDa) and beta  (38 kDa) subunits (13). The alpha 2 and alpha '2 are the catalytic subunits, whereas beta  appeared to have a regulatory function (23-25).2 The alpha 2 and alpha '2 subunits are immunologically cross-reactive and essentially identical to each other but are quite different from the beta  subunit. The alpha 2 subunit, which appears to be post-translationally processed to yield alpha '2 (13), is encoded by the MAT2A gene, which is homologous but different from MAT1A gene (11, 19, 24).

Previous studies had shown that physiological activation of human lymphocytes induces down-regulation of the beta  subunit with coincidental alterations in MAT II kinetic properties (25). We hypothesized that this differential expression of the beta  subunit may be an important physiological mechanism by which MAT II activity can be modulated. To test this hypothesis, we cloned and expressed both the ralpha 2 (24) and rbeta subunits2 of human MAT II in COS-1 cells, where mammalian post-translational events may affect subunit association and/or enzyme activity. In this study, we provide evidence for the association of MAT II alpha 2 and beta  subunits with consequent changes in enzyme kinetic and regulatory properties. We believe that this is an important mechanism by which AdoMet levels are controlled during cell growth and differentiation.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture

The COS-1 cells (African green monkey kidney fibroblasts, ATCC CRL 1650) were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% heat-inactivated fetal bovine serum (Atlanta Biologicals) and 10 mM L-glutamine (Cellgro).

Cloning of MAT II alpha 2 and beta  Subunits cDNA into Mammalian Expression Vectors

The full-length cDNA encoding human lymphocyte (HuLy) MAT II alpha 2 protein (24)2 was cloned into the pQE30 vector (Qiagen) designed to express protein with an N-terminal six-histidine (His) tag, and we introduced additional bases that encode for an enterokinase site to allow removal of the tag. The HuLy MAT II beta  cDNA was cloned into the same expression vector without the polyhistidine or the enterokinase site.2 The cloned cDNAs encoding either the ralpha 2 or the rbeta subunits were transferred from the pQE30 vector to the mammalian expression pTargeT vector (Promega) to generate pTargeT/MAT2A and pTargeT/MAT2B, respectively. Briefly, primers were designed to amplify the full-length cDNA encoding either the alpha 2 or the beta  subunits from the pQE30 vector. Amplification was done using Taq polymerase (Promega) and pfu (Stratagene) in the ratio of 5:1, and the amplified product containing an A-overhang was separated on 1% agarose gel in 0.5× TBE, purified, ligated into the mammalian expression vector, pTargeT, and used to transform Escherichia coli strain JM109 competent cells by heat shock. Positive colonies were selected and subcultured, and the plasmid DNA was purified (Qiagen). The purified plasmid DNA was tested for the presence of the cloned inserts of the correct size and orientation by both PCR and EcoRI restriction site analysis. DNA from six colonies containing the proper insert in the right direction were subjected to manual sequencing of the entire cDNA in both directions using DNA cycle sequencing reagents (Promega), and the sequence was compared with the previously confirmed cDNA sequence for the alpha 2 (24) or for the beta  subunit sequence2 to ensure that no mutations were introduced during amplification. One representative clone for either the alpha 2 or the beta  subunit insert was grown for large scale preparation of vector (Qiagen).

Transfection of COS-1 Cells

Transfection of COS-1 cells with pTargeT/MAT2A or pTargeT/MAT2B was done using the cationic lipid reagent, Transfast (Promega). Preliminary experiments were carried out to optimize the transfection conditions. Typically, 1.5 × 106 cells were plated in a 100-mm dish 1 day prior to transfection. For each plate, 15 µg of vector DNA was mixed with Transfast at a ratio of 1:1 and incubated in a protein-free medium for 2 h. For cells co-transfected with both alpha 2 and beta  vectors, 12 µg of DNA from each was used. For each experiment, one untransfected plate served as a normal control, and a second plate was transfected with the pTargeT vector only (mock-transfected cells). After 48 h, cells were harvested by trypsinization with a solution containing 0.05% trypsin and 0.53 mM EDTA in Hanks' balanced salt solution (from Cellgro), and the trypsinization was stopped by the addition of media supplemented with 10% fetal calf serum. The harvested cells were washed three times in 1 ml of Hanks' balanced salt solution, counted, and then resuspended in 1× extraction buffer containing protease inhibitors (50 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 4 mM dithiothreitol, 0.1 IU/ml aprotinin, 0.5 µM phenylmethylsulfonyl fluoride, and 30 µg/ml soybean trypsin inhibitor). Cells were lysed by three cycles of quick freezing and thawing, and the lysate was clarified by centrifugation at 15,000 × g for 10 min at 4 °C. If not immediately used, the cell extracts were stored at -80 °C. Protein assays were performed using the bicinchoninic acid reagent (Sigma) following the manufacturer's instructions.

Analysis of Expressed MAT II alpha 2 and beta  Subunits

Western Blot-- Extracts from normal, mock-transfected, and alpha 2- or beta -transfected COS-1 cells were prepared as described above, and 40 µg of protein from each cell extract were loaded onto 7.5% SDS-polyacrylamide gel (SDS-PAGE) after 1:1 dilution in 2× sample loading buffer (60 mM Tris, pH 6.8, 4% SDS, 5% 2-mercaptoethanol, and 5% glycerol) and boiling in a water bath for 5 min. For 17 × 17-cm gel size, electrophoresis was started at 100 V, and after the tracking dye left the stacking gel the current was kept constant at 30 mA for the remainder of the run. The gel was electroblotted onto a nitrocellulose membrane (Bio-Rad) for 1.5 h at 400 mA. After blocking overnight in 6% nonfat dry milk in Tris-buffered saline, the blot was sequentially incubated with primary rabbit anti-alpha 2 or anti-beta antibodies prepared as described previously (27, 28)2 followed by a secondary goat anti-rabbit antibody conjugated to horseradish peroxidase (Southern Biotechnology Associates, Inc.). The signal was initiated by the chemiluminescence reagents (ECL, Amersham Pharmacia Biotech) and detected using X-Omat film from Kodak. Molecular weight markers and recombinant MAT II (rMAT II) subunit proteins purified for E. coli extracts were used to determine the migration of expressed alpha 2 and beta  subunits.

Kinetic Properties of Expressed MAT II Subunits-- MAT activity in cell extracts was assayed as described previously (13). The assay mixture contained 5 mM ATP, 50 mM KCl, 15 mM MgCl2, 0.3 mM EDTA, 4 mM DTT in 50 mM TES buffer, pH 7.4). The concentration of L-Met was varied between 2 and 80 µM using 14C-L-Met (57.9 mCi/mmol) to a concentration of up to 20 µM and supplementary with cold L-Met for higher concentrations. Enzyme velocity is expressed as units/ml or units/mg protein, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h. Calculation of Km and Vmax was also done using the PSI-plot software (Poly Software International) and the Marquardt algorithm.

Analysis of the Expressed MAT II alpha 2 and beta  Subunit Interaction

Experiments were designed to determine whether the expressed alpha 2 and beta  subunits of MAT II associate and if their association alters the kinetic properties of the enzyme. Two methods were used to detect subunit association.

Analysis by Native Gel Electrophoresis-- Cell extracts were separated on 6% polyacrylamide gel in 1.5 M Tris, pH 8.8, under native conditions (without SDS). After blotting onto nitrocellulose membrane, the blots were probed with anti-alpha 2 antibodies, stripped, and then reprobed with anti-beta antibodies. Overlapping signals were taken as an evidence for co-migration of both subunits.

Analysis by Nickel-Agarose Bead Affinity Capture-- The association between the His-tagged alpha 2 subunit and the nontagged beta  subunit was analyzed by affinity purification on nickel-agarose beads (Qiagen). In a 15-ml tube, 2 ml of the 50% nickel-agarose slurry was spun down at 1000 rpm for 2 min, and then the pellet was equilibrated with a buffer containing 300 mM NaCl and 50 mM sodium phosphate, pH 8. Cellular extract containing about 10 mg of proteins was added and incubated for 30 min at 4 °C, with mixing on a vertical rotator. The equilibrated gel was poured into the column and allowed to settle. The column was washed several times with 5 ml of equilibration buffer until the absorbance at 280 mm of the go-through material was undetectable. Bound proteins were eluted with 5 ml of 300 mM imidazole, dialyzed against 20 mM Tris, pH 8, and lyophilized. The lyophilized proteins were reconstituted in 25 mM Tris buffer, pH 8, and the protein content was determined by the bicinchoninic acid reagent (Sigma). Proteins (2 µg each) were analyzed by SDS-PAGE as described above.

Separation of Recombinant and Endogenous MAT II Subunits from COS-1 Cell Extracts and Determination of AdoMet Feedback Inhibition of Enzyme Activity

Experiments were designed to test the effect of beta  subunit on the feedback inhibition of MAT II (alpha 2 subunit) by AdoMet. However, due to association of ralpha 2 with endogenous beta , as well as the association of the rbeta with the endogenous alpha 2 protein, it was necessary to purify the subunits away from each other and to test them separately and in combination for kinetic properties and inhibition by AdoMet. Protein extracts from COS-1 cells co-expressing alpha 2 and beta  subunits was fractionated on nickel-agarose column (Qiagen) as described above. The purified proteins were loaded onto a preparative 7.5% SDS-PAGE and after the separation was complete, and the protein bands were visualized by impregnation in cold 300 mM KCl. The alpha 2 or beta  bands were excised, and proteins were electroeluted from the gel separately into Tris-glycine buffer, pH 8, and dialyzed against 10 mM ammonium bicarbonate and then lyophilized. The lyophilized subunits were reconstituted, and the MAT assay was performed at 20 µM L-Met (as mentioned above) for alpha 2 subunit alone or alpha 2 plus beta  subunits (combined at a molar ratio of 1:1) in the absence or in the presence of 25-50 µM AdoMet.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Detection and Kinetic Analysis of rMAT II alpha 2 Subunit Expressed in COS-1 Cells-- COS-1 cells were transfected with pTargeT/MAT2A plasmid DNA. Protein extracts from untransfected, mock-transfected, and MAT2A-transfected cells were analyzed by Western blots. In untransfected and mock-transfected cells, small amounts of endogenous alpha 2, alpha 2', and beta  subunits were detected (Fig. 1, lanes 1 and 2); however, cells transfected with pTargeT/MAT2A expressed abundant amounts of the ralpha 2 protein, which migrated with a higher molecular weight due to the additional N-terminal polyhistidine tag and the enterokinase site (Fig. 1, lane 3). To study the effect of overexpression of ralpha 2 on MAT kinetics, extracts from untransfected and transfected cells were assayed for MAT activity at different concentrations of L-Met ranging from 2 to 80 µM. Transfection with pTargeT/MAT2A caused a 2-3-fold increase in MAT specific activity compared with untransfected cells (50 versus 20 units/mg of protein). In addition, expression of the ralpha 2 affected the enzyme Km for L-Met. MAT II in untransfected and mock-transfected cells had Km of 15 and 16 µM, respectively (Fig. 2, A and B), which are within the range found in resting human lymphocytes (23, 25). However, in cells expressing high levels of rMAT II alpha 2 protein, two kinetic forms with Km for L-Met of 17 and 75 µM could be discerned (Fig. 2C).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 1.   Expression of rMAT II alpha 2 subunit in COS-1 cells. COS-1 cells were transfected with pTargeT/MAT2A vector DNA as described under "Materials and Methods." The cells were harvested after 48 h, the proteins were extracted, and 40 µg of protein were applied to 7.5% SDS-PAGE. The separated proteins were transblotted onto a nitrocellulose membrane, which was probed with anti-MAT II alpha 2 and beta  antibodies. Lane 1, untransfected COS-1 cells; lane 2, mock-transfected cells; lane 3, MAT II alpha 2-transfected cells. The expressed ralpha 2 protein migrated at higher than the native alpha 2, since it contains an additional six His residues and an enterokinase site at the N-terminal end.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of overexpression of MAT II alpha 2 on the enzyme kinetics in COS-1 cells. Cellular protein extracts from untransfected, mock-transfected or pTargeT/MAT II2A-transfected COS-1 cells were assayed for MAT activity as described under "Materials and Methods," at different concentrations of L-Met. A Lineweaver-Burk plot (1/v versus 1/[L-Met]) was generated. A, normal cells; B, mock-transfected cells; C, alpha 2 cDNA-transfected cells. Enzyme velocity is expressed as units/ml or units/mg of protein, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h. Calculation of Km and Vmax was also done using the PSI-plot software (Poly Software International) and the Marquardt algorithm

Detection and Kinetic Analysis of MAT II beta  Expressed in COS-1 Cells-- COS-1 cells were transfected with pTargeT/MAT2B plasmid DNA, and the protein extracts from untransfected or transfected cells were analyzed by Western blots. Cells transfected with pTargeT/MAT2B expressed higher amounts of the rbeta protein compared with untransfected cells (Fig. 3, inset). Expression of MAT II beta  protein did not significantly affect the kinetic behavior of MAT II in normal cells (Fig. 3) inasmuch as the Km for L-Met was 20 µM; however, expression of rbeta caused an increase in Vmax and a ~2-fold increase in the MAT specific activity at different concentrations of L-Met (35 versus 20 units/mg of protein).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of overexpression of MAT II beta  on the enzyme kinetics in COS-1 cells. Cellular protein extract from pTargeT/MATIIB-transfected COS-1 cells was assayed for MAT activity as described under "Materials and Methods," at different concentrations of L-Met. Lineweaver-Burk plot (1/v versus 1/[L-methionine]) was used to calculate Km. The velocity is expressed as units/ml, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h. Inset, expression of MAT II beta  subunit in COS-1 cells. COS-1 cells were transfected with pTargeT/MAT2B vector DNA as described under "Materials and Methods." Cells were harvested after 48 h, proteins were extracted, and 40 µg were applied to 7.5% SDS-PAGE followed by transblotting onto nitrocellulose membrane, which was probed with anti-MAT II alpha 2 and beta  antibodies. Lane 1, untransfected COS-1 cells; lane 2, beta  cDNA-transfected cells.

Co-expression of MAT II alpha 2 and beta  Subunits-- COS-1 cells were co-transfected with pTargeT/MAT2A and pTargeT/MAT2B plasmid DNA, and the protein extracts from untransfected and transfected cells were analyzed by Western blots. As shown in Fig. 4, the cells that were co-transfected with both vectors expressed abundant amounts of the ralpha 2 and rbeta proteins compared with untransfected or mock-transfected cells.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   Co-expression of rMAT II alpha 2 and rMAT II beta  subunits in COS-1 cells. COS-1 cells were co-transfected with pTargeT/MAT2A (with His tag and enterokinase site) and pTargeT/MAT2B DNA as described under "Materials and Methods." Cells were harvested after 48 h, proteins were extracted, and 40 µg were applied to 7.5% SDS-PAGE followed by transblotting onto nitrocellulose membrane, which was probed with anti-MAT II alpha 2 and beta  antibodies. Lane 1, untransfected COS-1 cells; lane 2, alpha 2 and beta  cDNA-transfected cells.

Evidence for Association of MAT II alpha 2 and beta  Subunits-- The association between the alpha 2 and beta  subunits was assessed by different means. First, extracts from COS-1 cells co-transfected with vectors encoding alpha 2 and beta  subunits were subjected to PAGE gel separation under native conditions and blotted onto a nitrocellulose membrane that was sequentially probed with antibodies to ralpha 2 followed by antibodies to the beta  subunit, with stripping in between the probing. Both antibodies recognized the same bands on the transblot (Fig. 5), and this indicated the co-migration of both subunits under native conditions.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Co-migration of MAT II alpha 2 and beta  subunits on native PAGE. Forty micrograms of protein extracts from untransfected normal or rMAT II alpha 2- or ralpha 2beta -expressing cells were applied to 6% native polyacrylamide gel. The transblot was probed with antibody to the ralpha 2 protein (lane 1), developed with ECL, stripped, and then reprobed with antibody to rbeta protein (lane 2). A, untransfected cells; B, alpha 2-expressing cells; C, alpha 2beta -expressing cells.

Second, we took advantage of the selective His tag on the ralpha 2 subunit but not on the beta  subunit and used nickel-agarose to affinity-purify the alpha 2 subunit from extracts of COS-1 cells co-expressing ralpha 2 and rbeta subunits to test whether the beta  subunit associates with the alpha 2 subunit. As shown in Fig. 6A, analysis of the protein purified on nickel-agarose columns by SDS-PAGE showed that the rbeta subunit co-purified with the ralpha 2 subunit. Interestingly, when extracts from cells, which were individually expressing ralpha 2 or rbeta proteins, were simply mixed in a protein ratio of 1:1, the alpha 2 and beta  subunits also associated and co-purified on the nickel-agarose column (Fig. 6B), thereby indicating the spontaneous association of these proteins.


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 6.   MAT II alpha 2 and beta  subunits co-purify on nickel-agarose gel. rMAT II alpha 2, but not rMAT II beta , was expressed as a poly-His-tagged protein. Cellular protein extracts from untransfected and alpha 2-, beta -, and alpha 2beta -transfected COS-1 cells were loaded onto nickel-agarose columns. The captured proteins were eluted in 300 mM imidazole, dialyzed, and lyophilized. The reconstituted proteins were applied to SDS-PAGE and transblotted onto nitrocellulose membranes. Transblots were probed with anti-MAT II alpha 2 and beta  antibodies. Fig. 6A, lane 1, untransfected cell extract; lane 2, untransfected cell extract after separation on nickel-agarose; lane 3, alpha 2-expressing cell extract; lane 4, alpha 2-expressing cell extract after separation on nickel-agarose; lane 5, beta -expressing cell extract; lane 6, beta -expressing cell extract after separation on nickel-agarose; lane 7, alpha 2beta -co-expressing cell extract; lane 8, alpha 2beta -co-expressing cell extract after separation on nickel-agarose columns. The same purification procedure was followed for the mixed extracts from the alpha 2-expressing cells and the beta -expressing cells, and this was followed by analysis on SDS-PAGE (Fig. 6B). Lane 1, alpha 2-expressing cell extract; lane 2, alpha 2-expressing cell extract after separation on nickel-agarose; lane 3, beta -expressing cell extract; lane 4, beta -expressing cell extract after separation on nickel-agarose; lane 5, mixed extracts from alpha 2- and beta -expressing cells; lane 6, mixed extracts from alpha 2- and beta -expressing cells after separation on nickel-agarose column.

Together, the data provide evidence that the ralpha 2 subunit associates with the beta  subunit of MAT II. Interestingly, some of the native alpha 2 and alpha 2' subunits were also captured by the His-tagged ralpha 2 protein, suggesting heterologous oligomerization of alpha 2 and alpha 2' subunits with each other as well as with the beta  subunit.

Kinetic Analysis of MAT in Extracts from COS-1 Cells Co-expressing rMAT II alpha 2 and rbeta Subunits-- MAT activity was assayed in extracts of COS-1 cells expressing ralpha 2 only or co-expressing both ralpha 2 and rbeta subunits. MAT activity was increased by approximately 5-fold in the co-transfected cells as compared with untransfected or mock-transfected cells (Fig. 7). Further, co-expression of rbeta subunit caused an increase in MAT activity over that found in cells transfected with ralpha 2 alone. The Km for L-Met in extracts from COS-1 cells co-expressing both subunits indicated the presence of a single kinetic form of MAT II with Km of 20 µM (data not shown).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of co-expression of MAT II alpha 2 and beta  on MAT specific activity in COS-1 cells. Cellular protein extracts were assayed for MAT activity, as described under "Materials and Methods," at different concentrations of L-Met. Normal, untransfected COS-1 cells; mock, mock-transfected; alpha , alpha 2 cDNA-transfected; beta , beta  cDNA-transfected; alpha beta , alpha 2 cDNA- and beta  cDNA-co-transfected COS-1 cells. MAT activity is expressed as units/mg of protein, where 1 unit is defined as the formation of 1 nmol of AdoMet in 1 h.

Next we investigated whether the beta  subunit alters the feedback inhibition of MAT II by the product, AdoMet. The activity of the purified ralpha with and without rbeta was tested in the absence or in the presence of AdoMet. To rule out the possible association of either ralpha 2 or rbeta subunits with the endogenous MAT II subunits, we performed nickel-agarose column purification of extracts from COS-1 cells co-transfected with both subunits, separated the products on SDS-PAGE, excised the alpha 2 and beta  bands from the gel, electroeluted the protein, and purified each subunit separately. The purified subunits were mixed in equimolar ratios, and assayed for MAT activity in the presence and in the absence of AdoMet. While the addition of the beta  subunit significantly increased the catalytic activity of ralpha 2 by almost 2-fold, the presence of the beta  subunit rendered the enzyme more susceptible to AdoMet inhibition, with more than a 2-fold increase in the inhibitory effect of AdoMet seen when alpha 2 and beta  were combined (Fig. 8).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of rMAT II beta  on the feedback inhibition of MAT II by AdoMet. The MAT assay was conducted as described under "Materials and Methods," at 20 µM of L-Met. AdoMet was added at a final concentration of 25 or 50 µM to rMAT II alpha 2 in the absence or in the presence of the rMAT II beta  subunit.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The essential role of AdoMet in cellular metabolism is underscored by the fact that it participates in as many reactions as ATP and regulates the function of many key molecules and pathways (2, 3, 5, 6). It follows that understanding the regulation of synthesis of this pivotal compound is important. AdoMet is synthesized by MAT, which in mammalian cells exists as at least two isozymes; MAT I/III are confined to hepatic tissue, and MAT II is found in all tissues (3, 5). An emerging theme in the regulation of MAT activity in mammalian cells is that the differential oligomerization of the enzyme subunits can profoundly alter the enzyme physical properties, activity, and kinetic regulation. For example, the alpha 1 catalytic subunit of the hepatic form of MAT exists either as a dimer (MAT III) or a tetramer (MAT I). This difference in oligomeric forms results in profound changes in the hydrophobic properties of the enzyme; MAT I is nonhydrophobic, whereas MAT III is strongly hydrophobic (7, 29). Furthermore, MAT I is inhibited, while MAT III is activated by AdoMet, and the Km for L-Met for these two forms is 3-14 µM and 100-200 µM, respectively (16, 23, 30, 31). Although several elegant studies (9, 29, 31-33) have described means for the interconversion of MAT I and III, the physiologic relevance of the need to have these two forms of MAT in the liver remains unclear.

Unlike the hepatic forms of MAT, MAT II, which is present in all mammalian tissues, consists of nonidentical subunits alpha 2 and beta  (13). Previously, we reported that the alpha 2 subunit is catalytic and suggested that the beta  subunit has regulatory properties (13, 23-25).2 To directly assess the role of each MAT subunit in enzyme activity, it was essential to express these subunits in mammalian cells to ensure proper post-translational modification and to study whether these subunits associate and determine the consequence of this association on the kinetic properties of MAT II.

In this study, we provide evidence that the alpha 2 and beta  subunits of MAT II associate spontaneously and that this association alters the kinetic properties of the enzyme. nickel-agarose capture purification of the His-tagged ralpha 2 subunit from COS-1 cells co-expressing ralpha 2 and rbeta showed that the beta  subunit co-purified with the alpha 2 subunit. Interestingly, ralpha 2 oligomerized also with the endogenous alpha 2 and alpha 2' subunits, suggesting heterologous oligomerization of alpha 2, alpha 2', and beta  subunits of MAT II. The consequence of the differential oligomerization remains under investigation, but it is noteworthy that in cells expressing abundant amounts of ralpha 2 and low levels of endogenous beta  subunit, we could detect two kinetic forms of MAT II with Km values for L-Met of 17 and 75 µM. By contrast, in cells co-expressing ralpha 2 and rbeta , only one kinetic form of MAT II was detected with a Km for L-Met of 20 µM. We believe that the lower Km form represents oligomers of alpha 2/alpha 2' and beta , and the higher Km form found in cells overexpressing ralpha 2 protein represents homo-oligomeric alpha 2 subunits, which are in great excess of the endogenous beta  subunit. This conclusion is consistent with our previous findings that the Km for ralpha 2 is 80 µM (24)2 and that in physiologically stimulated peripheral blood mononuclear cells, where the expression of the beta  subunit is down-regulated and only the alpha 2 subunit is expressed, the Km for L-Met shifts from 20 µM to 55-67 µM (25).

Together, the data provide evidence that the MAT II beta  subunit associates with the alpha 2 subunit and lowers the Km for L-Met. The association between the alpha 2 and beta  subunit does not appear to require metabolically active cells, since it occurs spontaneously when purified ralpha 2 and rbeta protein were mixed; however, the molar ratio of each subunit in the holoenzyme remains to be determined. We hypothesize, based on our data, that alpha 2 can exist as homo-oligomers (dimers or tetramers) or as alpha 2/beta hetero-oligomers. The relative ratio of either form would depend on the relative molar concentration of alpha 2 to beta  subunits, which as we had previously reported can vary at different stages of lymphocyte activation (25). We believe that this may be an important mechanism by which MAT II can change its kinetic properties to synthesize different amounts of AdoMet, because in addition to its effect on lowering the Km for L-Met, the beta  subunit renders the enzyme more sensitive to AdoMet feedback inhibition.

The findings in this study provide a possible explanation for our recent observation that down-regulation of beta  subunit expression in activated lymphocytes results in 5-fold higher AdoMet levels in these cells (25). In these physiologically stimulated cells, the beta  subunit disappears after 72 h, and the alpha 2/alpha 2' subunits retain MAT activity with a Km for L-Met of 55-67 µM and are at least 2-fold more resistant to AdoMet feedback inhibition. As a result, there is an accumulation of higher amounts of intracellular AdoMet, reaching up to 100 µM compared with resting lymphocyte levels of 20 µM. Although we have not fully deciphered the physiologic importance of this observation, it is interesting to note that certain methyltransferases, including specific DNA methyltransferases that have a relatively high Km for AdoMet (26, 34) may be more active at the concentration attained in cells expressing only MAT II alpha 2 subunits.

In conclusion, the data reported here show that the association of MAT II alpha 2 and beta  subunits alters the kinetic and regulatory properties of the enzyme. We believe that this mode of regulation is important for adjusting the levels of AdoMet to meet the cellular requirements at different stages of differentiation and that this may be needed to regulate the expression of certain genes and/or the function of gene products.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant GM-54892-08 and Merit Review Award Funds from Veterans Affairs.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: University of Tennessee, Memphis, 956 Court Ave. Suite A-202, Memphis, TN 38163. Tel.: 901-448-7247; Fax: 901-448-7208; E-mail: Mkotb@utmem1. utmem.edu.

2 H. L. LeGros, A.-B. Halim, A. Geller, and M. Kotb, submitted for publication.

    ABBREVIATIONS

The abbreviations used are: MAT, methionine adenosyltransferase; rMAT, recombinant MAT; ralpha 2, recombinant alpha 2; rbeta , recombinant beta ; AdoMet, S-adenosylmethionine; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Cantoni, G. L. (1953) J. Biol. Chem. 204, 403-416[Free Full Text]
2. Tabor, C. W., and Tabor, H. (1984) Adv. Enzymol. Relat. Areas Mol. Biol. 56, 251-282[Medline] [Order article via Infotrieve]
3. Kotb, M., and Geller, A. M. (1993) Pharmacol. Ther. 59, 125-43[CrossRef][Medline] [Order article via Infotrieve]
4. Chiang, P. K., Gordon, R. K., Tal, J., Zeng, G. C., Doctor, B. P., Pardhasaradhi, K., and McCann, P. P. (1996) FASEB J. 10, 471-480[Abstract]
5. Mato, J. M., Alvarez, L., Ortiz, P., and Pajares, M. A. (1997) Pharmacol. Ther. 73, 265-80[CrossRef][Medline] [Order article via Infotrieve]
6. Finkelstein, J. D., Kyle, W. E., Martin, J. L., and Pick, A. M. (1975) Biochem. Biophys. Res. Commun. 66, 81-87[CrossRef][Medline] [Order article via Infotrieve]
7. Hoffman, J. L. (1983) Methods Enzymol. 94, 223-228[Medline] [Order article via Infotrieve]
8. Mudd, S. H., Levy, H. L., and Skovby, F. (1995) in The Molecular and Metabolic Basis of Inherited Diseases (Scriver, C. R. , Beaudet, A. L. , Sly, W. S. , and Valle, D., eds), 7th Ed. , McGraw-Hill Inc., New York
9. Mato, J. M., Alvarez, L., Ortiz, P., Mingorance, J., Duran, C., and Pajares, M. A. (1994) Adv. Exp. Med. Biol. 368, 113-117[Medline] [Order article via Infotrieve]
10. Okada, G., Teraoka, H., and Tsukada, K. (1981) Biochemistry 20, 934-940[CrossRef][Medline] [Order article via Infotrieve]
11. Kotb, M., Mudd, S. H., Mato, J. M., Geller, A. M., Kredich, N. M., Chou, J. Y., and Cantoni, G. L. (1997) Trends Genet. 13, 51-52[CrossRef][Medline] [Order article via Infotrieve]
12. Oden, K., and Clarke, S. (1983) Biochemistry 22, 2978-2986[CrossRef][Medline] [Order article via Infotrieve]
13. Kotb, M., and Kredich, N. M. (1985) J. Biol. Chem. 260, 3923-3930[Abstract/Free Full Text]
14. Langkamp-Henken, B., Geller, A. M., LeGros, H. L., Jr., Price, J. O., De la Rosa, J., and Kotb, M. (1994) Biochim. Biophys. Acta 1201, 397-404[Medline] [Order article via Infotrieve]
15. Liau, M. C., Chang, C. F., Belanger, L., and Grenier, A. (1979) Cancer Res. 39, 162-169[Abstract/Free Full Text]
16. Sullivan, D. M., and Hoffman, J. L. (1983) Biochemistry 22, 1636-1641[CrossRef][Medline] [Order article via Infotrieve]
17. Mitsui, K., Teraoka, H., and Tsukada, K. (1988) J. Biol. Chem. 263, 11211-11216[Abstract/Free Full Text]
18. Horikawa, S., Sasuga, J., Shimizu, K., Ozasa, H., and Tsukada, K. (1990) J. Biol. Chem. 265, 13683-13686[Abstract/Free Full Text]
19. Horikawa, S., and Tsukada, K. (1991) Biochem. Int. 25, 81-90[Medline] [Order article via Infotrieve]
20. Alvarez, L., Corrales, F., Martin-Duce, A., and Mato, J. M. (1993) Biochem. J. 293, 481-486
21. Sakata, S. F., Shelly, L. L., Ruppert, S., Schutz, G., and Chou, J. Y. (1993) J. Biol. Chem. 268, 13978-13986[Abstract/Free Full Text]
22. Ubagai, T., Lei, K. J., Huang, S., Mudd, S. H., Levy, H. L., and Chou, J. Y. (1995) J. Clin. Invest. 96, 1943-1947
23. De La Rosa, J., LeGros, H. L., Jr., Geller, A. M., and Kotb, M. (1992) J. Biol. Chem. 267, 10699-10704[Abstract/Free Full Text]
24. De La Rosa, J., Ostrowski, J., Hryniewicz, M. M., Kredich, N. M., Kotb, M., LeGros, H. L., Jr., Valentine, M., and Geller, A. M. (1995) J. Biol. Chem. 270, 21860-21868[Abstract/Free Full Text]
25. LeGros, H. L., Jr., Geller, A. M., and Kotb, M. (1997) J. Biol. Chem. 272, 16040-16047[Abstract/Free Full Text]
26. Roth, M., Helm-Kruse, S., Friedrich, T., and Jeltsch, A. (1998) J. Biol. Chem. 273, 17333-17342[Abstract/Free Full Text]
27. De La Rosa, J., Kotb, M., and Kredich, N. M. (1991) Biochim. Biophys. Acta 1077, 225-232[CrossRef][Medline] [Order article via Infotrieve]
28. Kotb, M., Geller, A. M., Markham, G. D., Kredich, N. M., De La Rosa, J., and Beachey, E. H. (1990) Biochim. Biophys. Acta 1040, 137-144[CrossRef][Medline] [Order article via Infotrieve]
29. Mingorance, J., Alvarez, L., Pajares, M. A., and Mato, J. M. (1997) Int. J. Biochem. Cell Biol. 29, 485-491[CrossRef][Medline] [Order article via Infotrieve]
30. Suma, Y., Shimizu, K., and Tsukada, K. (1986) J. Biochem. (Tokyo) 100, 67-75[Abstract/Free Full Text]
31. Pajares, M. A., Corrales, F., Duran, C., Mato, J. M., and Alvarez, L. (1992) FEBS Lett. 309, 1-4[CrossRef][Medline] [Order article via Infotrieve]
32. Corrales, F., Cabrero, C., Pajares, M. A., Ortiz, P., Martin-Duce, A., and Mato, J. M. (1990) Hepatology 11, 216-222[Medline] [Order article via Infotrieve]
33. Corrales, F., Ochoa, P., Rivas, C., Martin-Lomas, M., Mato, J. M., and Pajares, M. A. (1991) Hepatology 14, 528-533[CrossRef][Medline] [Order article via Infotrieve]
34. Fujioka, M. (1992) Int. J. Biochem. 24, 1917-1924[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. R. Attia, L. A. Gardner, E. Mahrous, D. J. Taxman, L. LeGros, S. Rowe, J. P.-Y. Ting, A. Geller, and M. Kotb
Selective Targeting of Leukemic Cell Growth in Vivo and in Vitro Using a Gene Silencing Approach to Diminish S-Adenosylmethionine Synthesis
J. Biol. Chem., November 7, 2008; 283(45): 30788 - 30795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Kim, S. L. Coon, S. Blackshaw, C. L. Cepko, M. Moller, S. Mukda, W.-Q. Zhao, C. G. Charlton, and D. C. Klein
Methionine Adenosyltransferase:Adrenergic-cAMP Mechanism Regulates a Daily Rhythm in Pineal Expression
J. Biol. Chem., January 7, 2005; 280(1): 677 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yang, M. R. Sadda, V. Yu, Y. Zeng, T. D. Lee, X. Ou, L. Chen, and S. C. Lu
Induction of Human Methionine Adenosyltransferase 2A Expression by Tumor Necrosis Factor {alpha}: ROLE OF NF-{kappa}B AND AP-1
J. Biol. Chem., December 19, 2003; 278(51): 50887 - 50896.
[Abstract] [Full Text] [PDF]


Home page